-
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
The Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
The Explainer -
The week's good news: Nov. 2, 2023
It wasn't all bad!
-
Young teen wins top science prize for soap that can treat skin cancer
Speed Read Memory of Ethiopian workers out in the sun inspired US schoolboy to make cell-reviving soap
Speed Read -
What is a 'feminist approach' to cancer care?
The Explainer 800,000 women die from 'preventable' cancers each year due to 'patriarchy', landmark study finds
The Explainer -
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
In Depth -
Study suggests ‘new car smell’ might be dangerous
Speed Read Drivers urged to keep the windows open to mitigate presence of chemical carcinogens
Speed Read -
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
In Depth -
What are ‘forever chemicals’ and how are they harmful?
feature The widely used pollutants have been linked to thyroid disease and cancers
feature -
Cancer makes man develop an Irish accent
feature And other stories from the stranger side of life
feature -
Dogs can differentiate between incompetent and nasty people
feature And other stories from the stranger side of life
feature -
Ticket Bank: London theatres take part in entertainment giveaway
feature Good news stories from the past seven days
feature -
mRNA technology and a vaccine for cancer
feature Cure is ‘in our grasp’ say the scientists behind the BioNTech Covid-19 jab
feature -
Do vegans live longer?
feature Plant-based lifestyles can drastically lower rates of some serious diseases
feature -
Sanofi/GSK/Haleon: cancer fears prove hard to stomach
Business Briefing Shares of GlaxoSmithKline, Sanofi and the new GSK spin-off, Haleon, all fell sharply last week
Business Briefing
